XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy, and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. Additional information on XORTX Therapeutics is available at www.XORTX.com.
Company Details
- Employees
- 8
- Address
- 3710 33rd Street Nw, Calgary,alberta T2l 2m1,canada
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- xortx.com
- HQ
- Calgary, Alberta
Xortx Therapeutics Inc. Questions
Xortx Therapeutics Inc.'s website is xortx.com
Xortx Therapeutics Inc.'s LinkedIn profile is https://ca.linkedin.com/company/xortx
Xortx Therapeutics Inc. has
8 employees.
View email and phone details for 8
employees at Xortx Therapeutics Inc..
Xortx Therapeutics Inc.'s industry is
Pharmaceutical Manufacturing
Xortx Therapeutics Inc.'s top competitors are
Marvel Biosciences Corp.,
Retinalogik Inc,
Flurotech,
Wave View Imaging Inc.,
Singularity Health,
Pulsemedica,
Pathalys Pharma,
Aquestive Therapeutics,
Evolutia Bio,
Hemostemix Inc..
Xortx Therapeutics Inc.'s categories are Pharmaceutical Manufacturing
